Delayed gastrointestinal recovery after abdominal operation – role of alvimopan

References

• VatherRTrivediSBissettIDefining postoperative ileus: results of a systematic review and global surveyJ Gastrointest Surg201317596297223377782
   PubMed Web of Science ®Google Scholar
• KalffJCSchrautWHSimmonsRLBauerAJSurgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileusAnn Surg199822856526639833803
   PubMed Web of Science ®Google Scholar
• BohnLMRaehalKMOpioid receptor signaling: relevance for gastrointestinal therapyCurr Opin Pharmacol20066655956316935560
   PubMed Web of Science ®Google Scholar
• GoldsteinJLMatuszewskiKADelaneyCPInpatient economic burden of postoperative ileus associated with abdominal surgery in the United StatesP T20073228290
   Google Scholar
• BasseLThorbølJELøsslKKehletHColonic surgery with accelerated rehabilitation or conventional careDis Colon Rectum2004473271277 discussion 277–27814991487
   PubMed Web of Science ®Google Scholar
• BeckerGBlumHENovel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileusLancet200937396701198120619217656
   PubMed Web of Science ®Google Scholar
• TaguchiASharmaNSaleemRMSelective postoperative inhibition of gastrointestinal opioid receptorsN Engl J Med20013451393594011575284
   PubMed Web of Science ®Google Scholar
• DelaneyCPWeeseJLHymanNHPhase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgeryDis Colon Rectum200548611141125 discussion 1125–1126; author reply 1127–112915906123
   PubMed Web of Science ®Google Scholar
• ViscusiERGoldsteinSWitkowskiTAlvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled studySurg Endosc2006201647016333556
   PubMed Web of Science ®Google Scholar
• WolffBGMichelassiFGerkinTMAlvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileusAnn Surg20042404728734 discussion 734–73515383800
   PubMed Web of Science ®Google Scholar
• HerzogTJColemanRLGuerrieriJPJrA double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomyAm J Obstet Gynecol2006195244545316626607
   PubMed Web of Science ®Google Scholar
• LudwigKEnkerWEDelaneyCPGastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathwayArch Surg2008143111098110519015469
   PubMed Web of Science ®Google Scholar
• LudwigKViscusiERWolffBGDelaneyCPSenagoreATechnerLAlvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysisWorld J Surg20103492185219020526599
   PubMed Web of Science ®Google Scholar
• TanEKCornishJDarziAWTekkisPPMeta-analysis: alvimopan vs placebo in the treatment of post-operative ileusAliment Pharmacol Ther2007251475717042776
   PubMed Web of Science ®Google Scholar
• Vaughan-ShawPGFecherICHarrisSKnightJSA meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospital length of stay and time to GI recovery in patients enrolled in a standardized accelerated recovery program after abdominal surgeryDis Colon Rectum201255561162022513441
   PubMed Web of Science ®Google Scholar
• LeeCTChangSSKamatAMAlvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trialEur Urol201466226527224630419
   PubMed Web of Science ®Google Scholar
• WolffBGWeeseJLLudwigKAPostoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resectionJ Am Coll Surg2007204460961617382220
   PubMed Web of Science ®Google Scholar
• MortensenEEntereg® (alvimopan) OBD study GSK014 safety findings2008 Available from: http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4336s1-04-Adolor-Mortensen.pdfAccessed June 2, 2015
   Google Scholar
• Cubist Pharmaceuticals IEntereg (alvimopan) risk evaluation and mitigation strategy (REMS)2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021775s010lbl.pdfAccessed June 2, 2015
   Google Scholar
• KaufTLSvatekRSAmielGAlvimopan, a peripherally acting µ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trialJ Urol201419161721172724342144
   PubMed Web of Science ®Google Scholar
• PostonSBroderMSGibbonsMMImpact of alvimopan (Entereg) on hospital costs after bowel resection: results from a large inpatient databaseP T201136420922021572777
   PubMedGoogle Scholar
• SimorovAThompsonJOleynikovDAlvimopan reduces length of stay and costs in patients undergoing segmental colonic resections: results from multicenter national administrative databaseAm J Surg20142086919925 discussion 92525440479
   PubMed Web of Science ®Google Scholar
• DelgadoSLacyAMFilellaXAcute phase response in laparoscopic and open colectomy in colon cancer: randomized studyDis Colon Rectum200144563864611357021
   PubMed Web of Science ®Google Scholar
• ObokhareIDChampagneBSteinSLKrpataDDelaneyCPThe effect of alvimopan on recovery after laparoscopic segmental colectomyDis Colon Rectum201154674374621552060
   PubMed Web of Science ®Google Scholar
• KelleySRWolffBGLovelyJKLarsonDWFast-track pathway for minimally invasive colorectal surgery with and without alvimopan (Entereg): which is more cost-effective?Am Surg201379663063323711275
   PubMed Web of Science ®Google Scholar
• LauCPhillipsEBreseeCFleshnerPEarly use of low residue diet is superior to clear liquid diet after elective colorectal surgery: a randomized controlled trialAnn Surg20142604641647 discussion 647–64925203881
   PubMed Web of Science ®Google Scholar